Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Jan 5;19(1):14.
doi: 10.1186/s12879-018-3614-7.

Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort

Kristina L Bajema  1 , Ingrid V Bassett  2 , Sharon M Coleman  3 , Douglas Ross  4 , Kenneth A Freedberg  2 , Anna Wald  5 , Paul K Drain  6   7
Affiliations
Clinical Trial

Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort

Kristina L Bajema et al. BMC Infect Dis. .

Abstract

Background: Subclinical tuberculosis is an asymptomatic disease phase with important relevance to persons living with HIV. We describe the prevalence, clinical characteristics, and risk of mortality for HIV-infected adults with subclinical tuberculosis.

Methods: Untreated adults with HIV presenting for outpatient care in Durban, South Africa were screened for tuberculosis-related symptoms and had sputum tested by acid-fast bacilli smear and tuberculosis culture. Active tuberculosis and subclinical tuberculosis were defined as having any tuberculosis symptom or no tuberculosis symptoms with culture-positive sputum. We evaluated the association between tuberculosis disease category and 12-month survival using Cox regression, adjusting for age, sex, and CD4 count.

Results: Among 654 participants, 96 were diagnosed with active tuberculosis disease and 28 with subclinical disease. The median CD4 count was 68 (interquartile range 39-161) cells/mm3 in patients with active tuberculosis, 136 (72-312) cells/mm3 in patients with subclinical disease, and 249 (125-394) cells/mm3 in those without tuberculosis disease (P < 0.001). The proportion of smear positive cases did not differ significantly between the subclinical (29%) and active tuberculosis groups (14%, P 0.08). Risk of mortality was not increased in individuals with subclinical tuberculosis relative to no tuberculosis (adjusted hazard ratio 0.84, 95% confidence interval 0.26-2.73).

Conclusions: Nearly one-quarter of tuberculosis cases among HIV-infected adults were subclinical, which was characterized by an intermediate degree of immunosuppression. Although there was no significant difference in survival, anti-tuberculous treatment of subclinical cases was common.

Trial registration: Prospectively registered on ClinicalTrials.gov , NCT01188941 (August 26, 2010).

Keywords: AIDS-related opportunistic infections; Disease progression; HIV; Subclinical infections; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The study was approved by the McCord Hospital Medical Research Ethics Committee, St. Mary’s Hospital Medical Research Ethics Committee, the University of KwaZulu-Natal Biomedical Research Ethics Committee, Partners Institutional Review Board, and the University of Washington Human Subjects Division. All participants provided written informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Kaplan Meier survival curves of adults with HIV stratified by tuberculosis status
See this image and copyright information in PMC

References

    1. World Health Organization. Global tuberculosis report. Geneva: 2017;1–147.
    1. Barry CE, 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009;7(12):845–855. doi: 10.1038/nrmicro2236. - DOI - PMC - PubMed
    1. Lawn SD, Wood R, Wilkinson RJ. Changing concepts of "latent tuberculosis infection" in patients living with HIV infection. Clin Dev Immunol. 2011;2011. - PMC - PubMed
    1. Achkar JM, Jenny-Avital ER. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J Infect Dis. 2011;204(Suppl 4):S1179–S1186. doi: 10.1093/infdis/jir451. - DOI - PMC - PubMed
    1. Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076. - PubMed

Publication types

MeSH terms

Substances

Associated data